Apeiron Investment Group Ltd., 10% Owner at Sensei Biotherapeutics, Inc. (SNSE), bought 2,200 shares at $1.62 ($4K) on 2023-02-23, disclosed to the SEC on 2023-02-27.
Open-market purchase of $4k SNSE by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.60 | 1,100 | $2K | 49.7% |
| 2 | $1.62 | 1,100 | $2K | 50.3% |
| Total | $1.61 avg | 2,200 | $4K | 100% |
| Filing → |
| ENHA | BUY | 2026-09-04 | $210K | — | Filing → |
| ENHA | BUY | 2026-08-20 | $2.9M | — | Filing → |
| ENHA | BUY | 2026-08-18 | $330K | — | Filing → |